Determination of zonisamide (3-sulphamoylmethyl-1,2-benzisoxazole) in plasma at therapeutic concentrations by high-performance liquid chromatography
- 1 January 1990
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 534, 173-181
- https://doi.org/10.1016/s0378-4347(00)82159-3
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Simultaneous determiantion of zonisamide and nine other anti-epileptic drugs and metabolites in serumJournal of Chromatography A, 1987
- Comparative Pharmacokinetics of Zonisamide (CI-912) in Epileptic Patients on Carbamazepine or Phenytoin MonotherapyTherapeutic Drug Monitoring, 1986
- Zonisamide in Epilepsy: A Pilot StudyEpilepsia, 1985
- Pilot Study of Zonisamide (1,2‐Benzisoxazole‐3‐methanesulfonamide) in Patients with Refractory Partial SeizuresEpilepsia, 1985
- Nonlinear Pharmacokinetics of CI-912 in Adult Epileptic PatientsTherapeutic Drug Monitoring, 1984
- Determination of valproic acid (dipropylacetic acid) in plasma by gas-liquid chromatographyJournal of Chromatography A, 1978
- Gas chromatographic analysis of ethosuximide (2-ethyl-2-methyl succinimide) in plasma at therapeutic concentrationsJournal of Chromatography A, 1978